Bone Biologics Corporation
BBLG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8,556 | $7,136 | $7,194 | $109,088 |
| - Cash | $3,325 | $3,027 | $7,538 | $6,675 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5,231 | $4,110 | -$345 | $102,412 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $107 | $480 | -$753 | -$806 |
| % Margin | – | – | – | – |
| Net Income | -$4,112 | -$8,949 | -$1,485 | -$1,611 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.83 | -34.01 | -31.2 | -37.35 |
| % Growth | 85.8% | -9% | 16.5% | – |
| Operating Cash Flow | -$4,125 | -$9,556 | -$3,567 | -$1,229 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$4,125 | -$9,556 | -$3,567 | -$1,229 |